Exploring ND-011992, a quinazoline-type inhibitor targeting quinone reductases and quinol oxidases

Abstract Bacterial energy metabolism has become a promising target for next-generation tuberculosis chemotherapy. One strategy to hamper ATP production is to inhibit the respiratory oxidases. The respiratory chain of Mycobacterium tuberculosis comprises a cytochrome bcc:aa 3 and a cytochrome bd ubiq...

Full description

Bibliographic Details
Main Authors: Jan Kägi, Willough Sloan, Johannes Schimpf, Hamid R. Nasiri, Dana Lashley, Thorsten Friedrich
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-39430-w